| NCT ID | NCT06686186 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hainan Medical College |
| Condition | Cognitive Impairment |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-12-16 |
| Primary Completion | 2053-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2022-12-16 with a primary completion date of 2053-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a community-based prospective cohort study in Hainan Province, China. The study was initialized in 2023 and included older residents for longitudinal follow-up. The research aims to identify risk factors as well as health and social outcomes that are associated with cognitive impairment in elderly populations, and independently develop AI-assisted software and applications for cognitive enhancement and physical rehabilitation training.
Eligibility Criteria
* Inclusion Criteria: * Age 60 years and above * Lived in the community for more than 6 months * Signed the informed consent form * Exclusion Criteria: * Cannot complete the survey
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06686186 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 120 Years, studying Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06686186 currently recruiting?
Yes, NCT06686186 is actively recruiting participants. Contact the research team at dingjindong@muhn.edu.cn for enrollment information.
Where is the NCT06686186 trial being conducted?
This trial is being conducted at Haikou, China.
Who is sponsoring the NCT06686186 clinical trial?
NCT06686186 is sponsored by Hainan Medical College. The trial plans to enroll 2,000 participants.